There are currently 7 terms in this directory beginning with the letter M.
Metastatic castration-resistant prostate cancer. mCRPC is a form of advanced prostate cancer that no longer responds to hormone treatments, shows signs of growth, and has spread to other parts of the body.
Metastatic castration-sensitive prostate cancer, also called metastatic hormone-sensitive prostate cancer (mHSPC). This is a form of prostate cancer that has spread beyond the prostate, or metastasized, but still responds to hormone treatment.
A medical oncologist is a physician who specializes in the non-surgical treatment of cancer with medicines such as chemotherapy, hormonal therapy, and other drugs. While many men with prostate cancer will work most closely with a urologist, it is important to include a medical oncologist in the early phases of treatment planning.
The spread of cancer from one part of the body to another. This happens through the lymph system or through the bloodstream. A tumor formed by cells that have spread is called a "metastatic tumor" or a "metastasis." The metastatic tumor contains cells that are like those in the original (primary) tumor.
Cancer has spread to other parts of the body, such as the bones, lymph nodes, lungs or liver.
Metastatic Hormone-Sensitive Prostate Cancer is cancer that has spread outside of the prostate and can still be treated with hormone therapy. This may also be called Metastatic Castration-Sensitive Prostate Cancer (mCSPC).
MRI (Magnetic Resonance Imaging)
MRIs use magnetic fields to create clear images of body parts, including tissues, muscles, nerves and bones. MRIs make better images of organs and soft tissue than other scanning techniques, such as computer tomography (CT) or x-ray. MRI is especially useful for imaging the brain, the spine, the soft tissue of joints and the inside of bones.